Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(21 sites)
Australia
Concord Repatriation General Hospital, Concord, New South Wales St George Hospital, Kogarah, New South Wales Liverpool Hospital, Liverpool, New South Wales John Hunter Hospital, New Lambton Heights, New South Wales Westmead Hospital, Westmead, New South Wales Sunshine Coast Hospital and Health Service, Birtinya, Queensland Princess Alexandra Hospital, Brisbane, Queensland Bundaberg Base Hospital, Bundaberg, Queensland Cairns Hospital, Cairns, Queensland Townsville Hospital, Douglas, Queensland Ipswich Hospital, Ipswich, Queensland Royal Melbourne Hospital, Melbourne, Victoria Sunshine Hospital (Western Health), St Albans, Victoria Royal Perth Hospital, Perth, Western Australia Royal Adelaide Hospital, Adelaide Monash Medical Centre, Clayton New Zealand
Dunedin Hospital, Dunedin Auckland City Hospital (Auckland DHB), Grafton North Shore Hospital (Waitemata DHB), Takapuna Tauranga Hospital, Tauranga Whangarei Hospital, Whangarei